Differential renal adverse effects of ibuprofen and indomethacin in preterm infants: a review

References

• CoburnRFEppingerRScottDPOxygen-dependent tension in vascular smooth muscle. Does the endothelium play a role?Circ Res1986583413473013456
   PubMed Web of Science ®Google Scholar
• CoceaniFAckerleyCSeidlitzEKelseyLFunction of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the ductus arteriosus from foetal lamb: differential development and change by oxygen and endotoxinBr J Pharmacol2001132124125111156583
   PubMed Web of Science ®Google Scholar
• CoceaniFOlleyPMBodachELamb ductus arteriosus: effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E2Prostaglandins1975922993081135442
   PubMed Web of Science ®Google Scholar
• DudellGGGersonyWMPatent ductus arteriosus in neonates with severe respiratory diseaseJ Pediatr19841049159206726527
   PubMed Web of Science ®Google Scholar
• EvansNJArcherLNPostnatal circulatory adaptation in healthy term and preterm neonatesArch Dis Child1990651 Spec24262306130
   PubMed Web of Science ®Google Scholar
• FayFSNairPWhalenWJMechanism of oxygen induced contraction of ductus arteriosusAdv Exp Med Biol197778123134899911
   PubMedGoogle Scholar
• GonzalezASosenkoIRChandarJHummlerHClaureNBancalariEInfluence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 grams or lessJ Pediatr199612844704788618179
   PubMed Web of Science ®Google Scholar
• HeymannMARudolphAMSilvermanNHClosure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesisN Engl J Med197629510530533950959
   PubMed Web of Science ®Google Scholar
• McMurphyDMHeymannMARudolphAMMelmonKLDevelopmental changes in constriction of the ductus arteriosus: responses to oxygen and vasoactive agents in the isolated ductus arteriosus of the fetal lambPediatr Res197264231238
   Web of Science ®Google Scholar
• Van OvermeireBSmetsKLecoutereDA comparison of ibuprofen and indomethacin for closure of patent ductus arteriosusN Engl J Med20003431067468110974130
   PubMed Web of Science ®Google Scholar
• RamsayJMMurphyDJJrVickGW3rdCourtneyJTGarcia-PratsJAHuhtaJCResponse of the patent ductus arteriosus to indomethacin treatmentAm J Dis Child198714132942973812411
   PubMedGoogle Scholar
• PaiVBSakadjianAPuthoffTDIbuprofen lysine for the prevention and treatment of patent ductus arteriosusPharmacotherapy20082811621182
   Web of Science ®Google Scholar
• OhlssonAWaliaRShahSSIbuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infantsCochrane Database Syst Rev20134CD00348123633310
   PubMed Web of Science ®Google Scholar
• VarvarigouABardinCLBeharryKChemtobSPapageorgiouAArandaJVEarly ibuprofen administration to prevent ductus arteriosus in premature newborn infantsJAMA199627575395448606475
   PubMed Web of Science ®Google Scholar
• KushnirAPinheiroJMComparison of renal effects of ibuprofen versus indomethacin during treatment of patent ductus arteriosus in contiguous historical cohortsBMC Clin Pharmacol2011118
   PubMedGoogle Scholar
• BagnoliFRossettiAMessinaGMoriACasucciMTomasiniBTreatment of patent ductus arteriosus (PDA) using ibuprofen: renal side-effects in VLBW and ELBW newbornsJ Matern Fetal Neonatal Med201326423429
   PubMed Web of Science ®Google Scholar
• YadavSAgarwalSMariaADudejaADubeyNKAnandPYadavDKComparison of oral ibuprofen with oral indomethacin for PDA closure in Indian preterm neonates: a randomized controlled trialPediatr Cardiol2014635582483024435507
   PubMed Web of Science ®Google Scholar
• OhlssonAWaliaRShahSSIbuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infantsCochrane Database Syst Rev20104CD00348120393936
   PubMed Web of Science ®Google Scholar
• HammermanCShchorsIJacobsonSIbuprofen versus continuous indomethacin in premature neonates with patent ductus arteriosus: is the difference in the mode of administration?Pediatr Res20086429129718458658
   PubMed Web of Science ®Google Scholar
• LagoPBettiolTSalvadoriSSafety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trialEur J Pediatr200216120220712014386
   PubMed Web of Science ®Google Scholar
• LeeCHChenHNTsaoLYHsiaoCCLeeMLOral ibuprofen versus intravenous indomethacin for closure of patent ductus arteriosus in very low birth weight infantsPaediatr Neonatol201253346353
   Web of Science ®Google Scholar
• LinderNBelloRHernandezATreatment of patent ductus arteriosus: indomethacin or ibuprofen?Am J Perinatol20102739940420013578
   PubMed Web of Science ®Google Scholar
• SrinivasjoisRMNathanEADohertyDAPatoleSKRenal impairment associated with indomethacin treatment for patent ductus arteriosus in extremely preterm neonates – is postnatal age at start of treatment important?J Matern Fetal Neonatal Med20061979379917190690
   PubMed Web of Science ®Google Scholar
• SuPHChenJYSuCMHuangTCLeeHSComparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infantsPediatr Int20034566567014651538
   PubMed Web of Science ®Google Scholar
• Van OvermeireBFollensIHartmannSCretenWLVan AckerKJTreatment of patent ductus arteriosus with ibuprofenArch Dis Child Fetal Neonatal Ed1997763F179F1849175948
   PubMed Web of Science ®Google Scholar
• SuBHLinHCChiuHYHsiehHYChenHHTsaiYCComparison of ibuprofen and indomethacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trialArch Dis Child Fetal Neonatal Ed2008932F94F99
   Web of Science ®Google Scholar
• OhlssonAShahSSIbuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infantsCochrane Database Syst Rev20117CD004213
   PubMed Web of Science ®Google Scholar
• OhlssonAWaliaRShahSIbuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infantsCochrane Database Syst Rev20081CD003481
   Web of Science ®Google Scholar
• ShahSSOhlssonAIbuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infantsCochrane Database Syst Rev20061CD00421316437478
   PubMed Web of Science ®Google Scholar
• GuimarãesHRochaGToméTAnatolitouFSarafidisKFanosVNon-steroid anti-inflammatory drugs in the treatment of patent ductus arteriosus in European newbornsJ Matern Fetal Neonatal Med200922Suppl 37780
   Web of Science ®Google Scholar
• GrosserTSmythEGarretAFitzGeraldAAnti-inflammatory, antipyretic, and analgesic agents; pharmacotherapy of goutBruntonLChabnerBKnollmanBGoodman and Gilman’s The Pharmacological Basis of TherapeuticsNew York, NYMcGraw-Hill2011973
   Google Scholar
• YoungTEMangumBCardiovascularNeofax: A Manual of Drugs Used in Neonatal Care23rd edMontvale, NJThomson Reuters2010178818
   Google Scholar
• HeyENeonatal Formulary: Drug Use in Pregnancy and the First Year of Life6th edBognor RegisJohn Wiley & Sons2011134139
   Google Scholar
• PacificiGMClinical pharmacology of indomethacin in preterm infants: implications in patent ductus arteriosus closurePaediatr Drugs201315536337623754139
   PubMed Web of Science ®Google Scholar